---
figid: PMC6470689__genes-10-00208-g001
figtitle: Proposed oncogenic mechanisms for Plk1
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Drosophila melanogaster
- Hepatitis B virus
pmcid: PMC6470689
filename: genes-10-00208-g001.jpg
figlink: /pmc/articles/PMC6470689/figure/genes-10-00208-f001/
number: F1
caption: Proposed oncogenic mechanisms for Plk1. (a) The Plk1-p53 negative feedback
  loop. Plk1 leads to p53 destabilization, directly by phosphorylation of p53 or MDM2,
  or indirectly mediated by Topors and/or GTSE1. Transcriptionally, p53 is able to
  repress Plk1 expression directly binding to its promoter region. (b) The Plk1-MYC
  positive feedback loop. Plk1 can stabilize and increase the levels of the oncogenic
  transcription factor MYC, directly inhibiting the SCFFbw7 ubiquitin ligase complex,
  or by activation of the AKT-GSK3β kinase circuit. These mechanisms have been described
  for neuroblastoma (NB), small cell lung carcinoma (SCLC) and double hit lymphoma
  (DHL). (c) Plk1 overexpression leads to degradation of the tumor suppressor REST
  in triple negative breast cancer (TNBC). (d) Plk1 activation by the hepatitis B
  virus HBx factor leads to degradation of the transcription repression factors SUZ12
  and ZNF198, both associated with the lncRNA HOTAIR in hepatocellular carcinoma.
  (e) Plk1 can activate the oncogenic PI3K pathway by inhibiting the PTEN tumor suppressor
  phosphatase. This leads to an increased cell proliferation rate and an elevated
  Warburg effect.
papertitle: 'The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?.'
reftext: Guillermo de Cárcer. Genes (Basel). 2019 Mar;10(3):208.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8901356
figid_alias: PMC6470689__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC6470689__F1
ndex: ae5f1dde-deb4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6470689__genes-10-00208-g001.html
  '@type': Dataset
  description: Proposed oncogenic mechanisms for Plk1. (a) The Plk1-p53 negative feedback
    loop. Plk1 leads to p53 destabilization, directly by phosphorylation of p53 or
    MDM2, or indirectly mediated by Topors and/or GTSE1. Transcriptionally, p53 is
    able to repress Plk1 expression directly binding to its promoter region. (b) The
    Plk1-MYC positive feedback loop. Plk1 can stabilize and increase the levels of
    the oncogenic transcription factor MYC, directly inhibiting the SCFFbw7 ubiquitin
    ligase complex, or by activation of the AKT-GSK3β kinase circuit. These mechanisms
    have been described for neuroblastoma (NB), small cell lung carcinoma (SCLC) and
    double hit lymphoma (DHL). (c) Plk1 overexpression leads to degradation of the
    tumor suppressor REST in triple negative breast cancer (TNBC). (d) Plk1 activation
    by the hepatitis B virus HBx factor leads to degradation of the transcription
    repression factors SUZ12 and ZNF198, both associated with the lncRNA HOTAIR in
    hepatocellular carcinoma. (e) Plk1 can activate the oncogenic PI3K pathway by
    inhibiting the PTEN tumor suppressor phosphatase. This leads to an increased cell
    proliferation rate and an elevated Warburg effect.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - hb
  - Plk1
  - Topors
  - Akt1
  - Gtse1
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Tex14
  - Pten
  - Fbxw7
  - Mdm2
  - Rest
  - Trp53
  - Zmym2
  - Suz12
  - pk
  - Hotair
  - Myc
  - Nol3
  - GSTM1
  - PLK1
  - TOPORS
  - AKT1
  - AKT2
  - AKT3
  - GTSE1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - TEX14
  - PTEN
  - FBXW7
  - MDM2
  - REST
  - TP53
  - TP63
  - TP73
  - ZMYM2
  - SUZ12
  - HOTAIR
  - SCLC1
  - HCC
  - HYCC1
  - PIGF
  - MYC
  - polo
  - Akt
  - dap
  - p53
  - betaTub60D
  - hth
  - Su(z)12
  - N-b
  - SCLC
---
